INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 46h ago
HOUSE PTR6h ago
SEC 13F6h ago
ROBINHOOD CHAIN6h ago
Corporate insider
TP

Treanor Patrick

DirectorCIK 0001929863

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score9
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
TP
Treanor PatrickDirector
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
10.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    KalVista Pharmaceuticals, Inc.Director · Jun 11, 2026
9
TP
Treanor PatrickDirector
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D
—
30.0K sh
Jun 11, 2026
Jun 11, 2026
traded Jun 11, 2026
+0d
SEC FORM 4

Evidence

9
TP
Treanor PatrickDirector
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
17.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC FORM 4

Evidence

9
TP
Treanor PatrickDirector
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
10.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC FORM 4

Evidence